Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrofurantoin vs Electrofulguration + Nitrofurantoin for Recurrent Cystitis
NCT06907199Phase 1Recruiting
- Sponsor
- UT Southwestern Medical Center
- Start
- Apr 2026
- Primary completion
- Jul 2028
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of nitrofurantoin in urinary tract infection (UTI) (2 arms), sponsored by UT Southwestern Medical Center. Primary endpoint: Treatment of cystitis with NF vs EF+NF at 30 months. Started Apr 2026; status: recruiting.
02
Drugs
nitrofurantoin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT06907199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06907199.